Financial results - ALL BIOPSY S.R.L.

Financial Summary - All Biopsy S.r.l.
Unique identification code: 40367597
Registration number: J2019000003335
Nace: 3250
Sales - Ron
122.743
Net Profit - Ron
10.126
Employees
1
Open Account
Company All Biopsy S.r.l. with Fiscal Code 40367597 recorded a turnover of 2024 of 122.743, with a net profit of 10.126 and having an average number of employees of 1. The company operates in the field of Fabricarea de dispozitive, aparate şi instrumente medicale stomatologice having the NACE code 3250.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - All Biopsy S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 51.818 32.305 106.676 423.666 195.612 122.743
Total Income - EUR - - - - 51.844 35.002 116.605 432.974 211.371 139.771
Total Expenses - EUR - - - - 18.629 32.838 53.192 109.227 137.347 127.186
Gross Profit/Loss - EUR - - - - 33.215 2.164 63.413 323.747 74.024 12.585
Net Profit/Loss - EUR - - - - 32.797 1.841 62.346 319.741 72.647 10.126
Employees - - - - 2 3 2 4 2 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -36.9%, from 195.612 euro in the year 2023, to 122.743 euro in 2024. The Net Profit decreased by -62.115 euro, from 72.647 euro in 2023, to 10.126 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - All Biopsy S.r.l.

Rating financiar

Financial Rating -
ALL BIOPSY S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
All Biopsy S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
All Biopsy S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
All Biopsy S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - All Biopsy S.r.l. - CUI 40367597

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 24.554 20.403 10.385 8.496 16.310 29.487
Current Assets - - - - 71.938 75.163 137.930 462.610 491.544 82.571
Inventories - - - - 0 2.549 0 6.379 6.233 1.275
Receivables - - - - 71.114 72.603 136.293 456.247 471.166 77.735
Cash - - - - 824 11 1.637 -17 14.145 3.562
Shareholders Funds - - - - 32.839 34.058 95.649 415.686 426.424 10.166
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 26.118 24.685 24.139 26.803 61.190 96.986
Income in Advance - - - - 37.535 36.824 28.527 28.616 20.240 4.906
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "3250 - 3250"
CAEN Financial Year 3250
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 82.571 euro in 2024 which includes Inventories of 1.275 euro, Receivables of 77.735 euro and cash availability of 3.562 euro.
The company's Equity was valued at 10.166 euro, while total Liabilities amounted to 96.986 euro. Equity decreased by -413.875 euro, from 426.424 euro in 2023, to 10.166 in 2024. The Debt Ratio was 86.6% in the year 2024.

Risk Reports Prices

Reviews - All Biopsy S.r.l.

Comments - All Biopsy S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.